Metabolite Chemistry Reagents - Medical Devices Pipeline Assessment, 2017

2017-09-01
Price :
Published : Sep-2017
No. of Pages : 90
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Metabolite Chemistry Reagents Overview 6
3 Products under Development 7
3.1 Metabolite Chemistry Reagents - Pipeline Products by Stage of Development 7
3.2 Metabolite Chemistry Reagents - Pipeline Products by Territory 8
3.3 Metabolite Chemistry Reagents - Pipeline Products by Regulatory Path 9
4 Metabolite Chemistry Reagents - Pipeline Products under Development by Companies 10
4.1 Metabolite Chemistry Reagents Companies - Pipeline Products by Stage of Development 10
4.2 Metabolite Chemistry Reagents - Pipeline Products by Stage of Development 11
5 Metabolite Chemistry Reagents Companies and Product Overview 12
5.1 A/C Diagnostics LLC Company Overview 12
5.1.1 A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Advanced Liquid Logic Inc Company Overview 13
5.2.1 Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 14
5.3.1 Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
5.4 Analyticon Biotechnologies AG Company Overview 15
5.4.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 15
5.5 BG Medicine Inc Company Overview 33
5.5.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.6 Genesis Detection Systems, Inc. Company Overview 34
5.6.1 Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 Healthmed Services Ltd. (Inactive) Company Overview 35
5.7.1 Healthmed Services Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
5.8 Instrumentation Laboratory Company Company Overview 36
5.8.1 Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 36
5.9 iXensor Co. Ltd. Company Overview 37
5.9.1 iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
5.10 Luminor Medical Technologies Inc Company Overview 38
5.10.1 Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.11 Ohmx Corp Company Overview 39
5.11.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 39
5.12 Siemens Healthcare GmbH Company Overview 40
5.12.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
5.13 The Binding Site Group Ltd Company Overview 41
5.13.1 The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
5.14 Versantis AG Company Overview 42
5.14.1 Versantis AG Pipeline Products & Ongoing Clinical Trials Overview 42
6 Metabolite Chemistry Reagents- Recent Developments 43
6.1 Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 43
6.2 Aug 01, 2017: Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 44
6.3 Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results 45
6.4 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 47
6.5 Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin 50
6.6 Jul 03, 2017: Premaitha Health Litigation Update 50
6.7 Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017 51
6.8 May 22, 2017: Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Genomics Expertise and Strong Commercial Leadership Experience to the Role 52
6.9 May 18, 2017: Aalto Bio Reagents Launches West Nile Virus Native and Recombinant Proteins for Diagnostic Testing 52
6.10 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 53
6.11 May 02, 2017: Oxford Immunotec Reports First Quarter 2017 Financial Results 55
6.12 Apr 25, 2017: Illumina Reports Financial Results for First Quarter of Fiscal Year 2017 56
6.13 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 57
6.14 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 60
6.15 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 60
6.16 Mar 31, 2017: HORIBA Instruments commences operations at new factory in Houston 61
6.17 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 62
6.18 Mar 20, 2017: EKF Diagnostics Holdings: Final results 62
6.19 Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO 63
6.20 Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment 63
6.21 Feb 20, 2017: Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina 63
6.22 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 64
6.23 Jan 31, 2017: Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016 66
6.24 Jan 27, 2017: Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries 67
6.25 Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 68
6.26 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 68
6.27 Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change 69
6.28 Jan 03, 2017: Illumina Taps Garret Hampton, One of the World's Leading Clinical Genomics Experts, to Head its Clinical Genomics Unit 69
6.29 Dec 22, 2016: Bionaturis Group gets a new patent in USA innovating in the use of natural resources to produce pharmaceutical products 70
6.30 Dec 20, 2016: Illumina Names Jonathan Seaton as Senior Vice President for Corporate & Business Development, Adding Further Clinical and Life Sciences Expertise to its Executive Team 70
6.31 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 70
6.32 Dec 14, 2016: Siemens Healthineers to significantly expand its Walpole, Mass. Laboratory Diagnostic manufacturing facility 71
6.33 Dec 07, 2016: Illumina appoints senior vice president and CFO 72
6.34 Dec 07, 2016: Illumina Extends Management Team, Appoints Sam A. Samad as Senior Vice President and Chief Financial Officer 72
6.35 Nov 25, 2016: Immunodiagnostic Systems Holdings: Interim Results for the six month period ended 30 September 2016 73
6.36 Nov 01, 2016: Oxford Immunotec Reports Third Quarter 2016 Financial Results 73
6.37 Nov 01, 2016: Illumina Reports Full Financial Results for Third Quarter of Fiscal Year 2016 75
6.38 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 76
6.39 Oct 21, 2016: Immunodiagnostic Systems Holdings: H1 Trading Update 79
6.40 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 81
6.41 Oct 10, 2016: Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016 83
6.42 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 84
7 Appendix 87
7.1 Methodology 87
7.2 About GlobalData 90
7.3 Contact Us 90
7.4 Disclaimer 90

1.1 List of Tables
Table 1: Metabolite Chemistry Reagents - Pipeline Products by Stage of Development 7
Table 2: Metabolite Chemistry Reagents - Pipeline Products by Territory 8
Table 3: Metabolite Chemistry Reagents - Pipeline Products by Regulatory Path 9
Table 4: Metabolite Chemistry Reagents Companies - Pipeline Products by Stage of Development 10
Table 5: Metabolite Chemistry Reagents - Pipeline Products by Stage of Development 11
Table 6: A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 12
Table 7: Folate Enzymatic Assay - Product Status 12
Table 8: Folate Enzymatic Assay - Product Description 12
Table 9: Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview 13
Table 10: Total Serum Biliruibin Multiplex Assay - Product Status 13
Table 11: Total Serum Biliruibin Multiplex Assay - Product Description 13
Table 12: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
Table 13: ACE Alera Clinical Chemistry System - Neonatal Bilirubin Assay - Product Status 14
Table 14: ACE Alera Clinical Chemistry System - Neonatal Bilirubin Assay - Product Description 14
Table 15: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 15
Table 16: BIL-Direct JG Fluitest - Product Status 16
Table 17: BIL-Direct JG Fluitest - Product Description 16
Table 18: BIL-Total JG Fluitest - Product Status 16
Table 19: BIL-Total JG Fluitest - Product Description 17
Table 20: BIL-Total VBM Fluitest - Product Status 17
Table 21: BIL-Total VBM Fluitest - Product Description 17
Table 22: BIL-Total WG Fluitest - Product Status 18
Table 23: BIL-Total WG Fluitest - Product Description 18
Table 24: BILD-DCA Fluitest - Product Status 18
Table 25: BILD-DCA Fluitest - Product Description 19
Table 26: BILT-DCA Fluitest - Product Status 19
Table 27: BILT-DCA Fluitest - Product Description 19
Table 28: CHOL - HDL Direct Fluitest - Product Status 20
Table 29: CHOL - HDL Direct Fluitest - Product Description 20
Table 30: CHOL - LDL Direct Fluitest - Product Status 20
Table 31: CHOL - LDL Direct Fluitest - Product Description 21
Table 32: CHOL - LDL Fluitest - Product Status 21
Table 33: CHOL - LDL Fluitest - Product Description 21
Table 34: CHOL CHOD-PAP Lyophilisat - Product Status 22
Table 35: CHOL CHOD-PAP Lyophilisat - Product Description 22
Table 36: CHOL Fluitest - Product Status 22
Table 37: CHOL Fluitest - Product Description 23
Table 38: Fluitest ALB-BCG - Product Status 23
Table 39: Fluitest ALB-BCG - Product Description 23
Table 40: Fluitest BIL - Direct Walters/Gerarde - Product Status 24
Table 41: Fluitest BIL - Direct Walters/Gerarde - Product Description 24
Table 42: Fluitest BIL T/D - Product Status 24
Table 43: Fluitest BIL T/D - Product Description 25
Table 44: Fluitest CHOL-HDL Phosphotungstic Acid/Magnesium Chloride - Product Status 25
Table 45: Fluitest CHOL-HDL Phosphotungstic Acid/Magnesium Chloride - Product Description 25
Table 46: Fluitest CREA - Kinetic - Product Status 26
Table 47: Fluitest CREA - Kinetic - Product Description 26
Table 48: Fluitest FE FZ - Product Status 26
Table 49: Fluitest FE FZ - Product Description 27
Table 50: Fluitest FRUC - Product Status 27
Table 51: Fluitest FRUC - Product Description 28
Table 52: Fluitest GLU GOD-PAP - Product Status 28
Table 53: Fluitest GLU GOD-PAP - Product Description 28
Table 54: Fluitest LA PAP - Product Status 29
Table 55: Fluitest LA PAP - Product Description 29
Table 56: GLU GOD - PAP Lyophilisat - Product Status 29
Table 57: GLU GOD - PAP Lyophilisat - Product Description 30
Table 58: HbA1 Ion Exchange Batch Assay - Product Status 30
Table 59: HbA1 Ion Exchange Batch Assay - Product Description 30
Table 60: HbA1c Micro Column Assay - Product Status 31
Table 61: HbA1c Micro Column Assay - Product Description 31
Table 62: Turbitex FER - Product Status 31
Table 63: Turbitex FER - Product Description 32
Table 64: Turbitex HbA1c/Hb Assay - Product Status 32
Table 65: Turbitex HbA1c/Hb Assay - Product Description 32
Table 66: BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 67: LipidDx - Product Status 33
Table 68: LipidDx - Product Description 33
Table 69: Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 70: Rapid Home Test - HDL/LDL Cholesterol - Product Status 34
Table 71: Rapid Home Test - HDL/LDL Cholesterol - Product Description 34
Table 72: Healthmed Services Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
Table 73: Glycated Albumin Test - Product Status 35
Table 74: Glycated Albumin Test - Product Description 35
Table 75: Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 36
Table 76: GEM Premier 4000 Analyzer - BUN - Product Status 36
Table 77: GEM Premier 4000 Analyzer - BUN - Product Description 36
Table 78: iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 79: Uric Acid Test - Product Status 37
Table 80: Uric Acid Test - Product Description 37
Table 81: Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 82: Next Generation PreVu LP Test - Product Status 38
Table 83: Next Generation PreVu LP Test - Product Description 38
Table 84: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 39
Table 85: Diagnostic Test - FAD Metabolite - Product Status 39
Table 86: Diagnostic Test - FAD Metabolite - Product Description 39
Table 87: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
Table 88: ADVIA 1800 Chemistry System - Creatinine Validity Test - Product Status 40
Table 89: ADVIA 1800 Chemistry System - Creatinine Validity Test - Product Description 40
Table 90: The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 91: Albumin Urine SPAplus Kit - Product Status 41
Table 92: Albumin Urine SPAplus Kit - Product Description 41
Table 93: Versantis AG Pipeline Products & Ongoing Clinical Trials Overview 42
Table 94: TS-01 - Product Status 42
Table 95: TS-01 - Product Description 42
Table 96: Glossary 89

1.2 List of Figures
Figure 1: Metabolite Chemistry Reagents - Pipeline Products by Stage of Development 7
Figure 2: Metabolite Chemistry Reagents - Pipeline Products by Territory 8
Figure 3: Metabolite Chemistry Reagents - Pipeline Products by Regulatory Path 9
Filed in: Medical Device
Publisher : GlobalData